Streetbeat News

Analyst Ratings

GFS

JP Morgan analyst Harlan Sur downgraded GLOBALFOUNDRIES (NASDAQ:GFS) from Overweight to Neutral and reduced the price target from $65 to $56. This adjustment reflects a more cautious stance on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:42 am

PLRX

HC Wainwright & Co. analyst Ed Arce maintains a Buy rating on Pliant Therapeutics (NASDAQ:PLRX) but lowers the price target from $52 to $48.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:36 am

TPR

Evercore ISI Group analyst Michael Binetti upgraded Tapestry (NYSE:TPR) from In-Line to Outperform and increased the price target from $30 to $50.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:35 am

HOTH

HC Wainwright & Co. analyst Raghuram Selvaraju has initiated coverage on Hoth Therapeutics (NASDAQ:HOTH) with a Buy rating and set a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:33 am

SKYW

TD Cowen analyst Helane Becker has upgraded SkyWest (NASDAQ:SKYW) from Market Perform to Outperform and increased the price target from $55 to $68.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:32 am

CI

RBC Capital analyst Frank Morgan upgrades Cigna Group (NYSE:CI) from Sector Perform to Outperform and raises the price target from $327 to $354.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:27 am

MEG

Stifel analyst Noelle Dilts reinstated a Buy rating on Montrose Environmental Gr (NYSE:MEG) with a $36 price target.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:24 am

SDHC

RBC Capital analyst Mike Dahl has initiated coverage on Smith Douglas Homes (NYSE:SDHC) with a Sector Perform rating and set a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:22 am

TME

Redburn Atlantic analyst Agnieszka Pustula initiates coverage on Tencent Music Enter Gr (TME) with a Buy rating and a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:16 am

SLNO

Piper Sandler analyst Yasmeen Rahimi has initiated coverage on Soleno Therapeutics (NASDAQ:SLNO) with an Overweight rating and set a price target of $93.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 11:14 am